BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15997466)

  • 1. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions.
    Larsen MV; Lundegaard C; Lamberth K; Buus S; Brunak S; Lund O; Nielsen M
    Eur J Immunol; 2005 Aug; 35(8):2295-303. PubMed ID: 15997466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction.
    Larsen MV; Lundegaard C; Lamberth K; Buus S; Lund O; Nielsen M
    BMC Bioinformatics; 2007 Oct; 8():424. PubMed ID: 17973982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NetCTLpan: pan-specific MHC class I pathway epitope predictions.
    Stranzl T; Larsen MV; Lundegaard C; Nielsen M
    Immunogenetics; 2010 Jun; 62(6):357-68. PubMed ID: 20379710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding.
    Tenzer S; Peters B; Bulik S; Schoor O; Lemmel C; Schatz MM; Kloetzel PM; Rammensee HG; Schild H; Holzhütter HG
    Cell Mol Life Sci; 2005 May; 62(9):1025-37. PubMed ID: 15868101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated modeling of the major events in the MHC class I antigen processing pathway.
    Dönnes P; Kohlbacher O
    Protein Sci; 2005 Aug; 14(8):2132-40. PubMed ID: 15987883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
    López D; Gil-Torregrosa BC; Bergmann C; Del Val M
    J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
    Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
    J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.
    Weinzierl AO; Rudolf D; Hillen N; Tenzer S; van Endert P; Schild H; Rammensee HG; Stevanović S
    Eur J Immunol; 2008 Jun; 38(6):1503-10. PubMed ID: 18446792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors.
    Peters B; Bulik S; Tampe R; Van Endert PM; Holzhütter HG
    J Immunol; 2003 Aug; 171(4):1741-9. PubMed ID: 12902473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class I T-cell epitope prediction: improvements using a combination of proteasome cleavage, TAP affinity, and MHC binding.
    Doytchinova IA; Flower DR
    Mol Immunol; 2006 May; 43(13):2037-44. PubMed ID: 16524630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage.
    Nielsen M; Lundegaard C; Lund O; Keşmir C
    Immunogenetics; 2005 Apr; 57(1-2):33-41. PubMed ID: 15744535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NetTepi: an integrated method for the prediction of T cell epitopes.
    Trolle T; Nielsen M
    Immunogenetics; 2014 Aug; 66(7-8):449-56. PubMed ID: 24863339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-Specific Prediction of Peptide-MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity.
    Rasmussen M; Fenoy E; Harndahl M; Kristensen AB; Nielsen IK; Nielsen M; Buus S
    J Immunol; 2016 Aug; 197(4):1517-24. PubMed ID: 27402703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational prediction of cleavage using proteasomal in vitro digestion and MHC I ligand data.
    Lu YF; Sheng H; Zhang Y; Li ZY
    J Zhejiang Univ Sci B; 2013 Sep; 14(9):816-28. PubMed ID: 24009202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
    Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets.
    Nielsen M; Andreatta M
    Genome Med; 2016 Mar; 8(1):33. PubMed ID: 27029192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
    Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
    Front Immunol; 2018; 9():1795. PubMed ID: 30127785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAProC: a prediction algorithm for proteasomal cleavages available on the WWW.
    Nussbaum AK; Kuttler C; Hadeler KP; Rammensee HG; Schild H
    Immunogenetics; 2001 Mar; 53(2):87-94. PubMed ID: 11345595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell epitope processing (the epitope flanking regions matter).
    Martinez AN; Tenzer S; Schild H
    Methods Mol Biol; 2009; 524():407-15. PubMed ID: 19377961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.